EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer

NCT00049231 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: EF5
OTHER: immunohistochemistry staining method
PROCEDURE: biopsy

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]